GWM
RTO icon

Geneos Wealth Management’s Rentokil RTO Stock Holding History

Geneos Wealth Management’s Portfolio RTO Stock Details RTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$242K Sell
8,444
-52
-0.6% -$1.65K ﹤0.01% 926
2026
Q1 		$267K Sell
8,496
-640
-7% -$20.2K 0.01% 867
2025
Q4 		$269K Buy
9,136
+8,656
+1,803% +$240K 0.01% 830
2025
Q3 		$12.1K Sell
480
-126
-21% -$3.07K ﹤0.01% 1897
2025
Q2 		$14.5K Sell
606
-21
-3% -$487 ﹤0.01% 2169
2025
Q1 		$14.4K Sell
627
-67
-10% -$1.62K ﹤0.01% 2093
2024
Q4 		$17.6K Buy
+694
New +$17.6K ﹤0.01% 1791

Other funds holding RTO

JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
GCM
Gates Capital Management New York $4.16B AUM 21% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.9% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.79B AUM 33.56% 1-Year Est. Return
Aristotle Capital Management
Aristotle Capital Management Los Angeles, California $47.7B AUM 13.92% 1-Year Est. Return
SL
Summitry LLC Foster City, California $3.04B AUM 17.05% 1-Year Est. Return

Geneos Wealth Management's RTO Position: Q2 2026 in Review

Geneos Wealth Management reduced its Rentokil (RTO) stake by 0.61% in Q2 2026, selling an estimated $1.65K and leaving 8,444 shares worth $242K. The position accounts for ﹤0.01% of the portfolio, ranked #926.

Geneos Wealth Management first reported a position in RTO in Q4 2024 and has held it in 7 quarters since. The position peaked at $269K in Q4 2025. 284 funds tracked by Wall St. Rank hold RTO as of Q2 2026.

  • Geneos Wealth Management held 8,444 shares of Rentokil worth $242K as of Q2 2026.
  • Geneos Wealth Management sold 52 Rentokil shares in Q2 2026, an estimated $1.65K.
  • Rentokil made up ﹤0.01% of Geneos Wealth Management's portfolio in Q2 2026, its #926 holding.
  • Geneos Wealth Management first reported a position in Rentokil in Q4 2024 and has held it in 7 quarters since.
  • Geneos Wealth Management's Rentokil position peaked at $269K in Q4 2025.
  • 284 funds tracked by Wall St. Rank held Rentokil as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.